D
Aura Biosciences, Inc. AURA
$5.67 $0.448.41%
Recommendation
Sell
Prev Close
$5.52
Volume
176,025
Avg Vol (90D)
226,733
Market Cap
$277.24M
Dividend & Yield
--
52-Week Range
$5.08 - $12.38
P/E (TTM)
--
EPS (TTM)
-$1.75
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Weak
Efficiency Index
Very Weak
Solvency Index
Excellent
Total Return Index
Weak
Volatility Index
Weak
Dividend Index
--
Headlines
Is Aura Biosciences (AURA) The Small Cap Stock with Huge Upside Potential?
4/6/2025 - Insider Monkey
Is Aura Biosciences (AURA) The Small Cap Stock with Huge Upside Potential?
4/6/2025 - Yahoo! Finance: News
10 Small Cap Stocks with Huge Upside Potential
4/6/2025 - Insider Monkey
Aura Biosciences Inc (AURA) Receives a Buy from Scotiabank
4/3/2025 - TipRanks Financial Blog
Aura Biosciences Announces Appointment of Teresa Bitetti to Board of Directors
4/2/2025 - GuruFocus
Aura Biosciences appoints Bitetti to board of directors
4/2/2025 - TipRanks Financial Blog
Aura Biosciences appoints Bitetti to board of directors
4/2/2025 - The Fly
Aura Biosciences Announces Appointment of Teresa Bitetti to Board of Directors
4/2/2025 - Globe Newswire
Aura Biosciences (AURA, $6.34) Aroon Indicator entered a Downtrend on March 28, 2025.
3/29/2025 - Tickeron - Stocks
Aura Biosciences (AURA, $5.94) Aroon Indicator entered a Downtrend on March 27, 2025.
3/28/2025 - Tickeron - Stocks
Institutional investors may adopt severe steps after Aura Biosciences, Inc.'s (NASDAQ:AURA) latest 20% drop adds to a year losses
3/27/2025 - Simply Wall St
Aura Biosciences (AURA, $5.99) Aroon Indicator entered a Downtrend on March 26, 2025.
3/27/2025 - Tickeron - Stocks
Aura Biosciences (NASDAQ:AURA) Issues Quarterly Earnings Results
3/26/2025 - MarketBeat
Aura Biosciences price target lowered by $2 at Citizens JMP, here's why
3/26/2025 - The Fly
Aura Biosciences, Inc (AURA) Virtual Urologic Oncology Investor Event Call (Transcript)
3/25/2025 - Seeking Alpha: Transcripts
Aura Biosciences, Inc (AURA) Virtual Urologic Oncology Investor Event Call (Transcript)
3/25/2025 - SeekingAlpha
HC Wainwright Reiterates Buy Rating for Aura Biosciences (NASDAQ:AURA)
3/25/2025 - MarketBeat
Scotiabank Sticks to Its Buy Rating for Aura Biosciences Inc (AURA)
3/25/2025 - TipRanks Financial Blog
Aura Biosciences price target raised by $3 at H.C. Wainwright, here's why
3/25/2025 - The Fly
Aura Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
3/24/2025 - GuruFocus
Aura Biosciences GAAP EPS of -$1.75 misses by $0.07
3/24/2025 - SeekingAlpha.com: All News
Aura Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
3/24/2025 - Globe Newswire
Aura Biosciences announces data from Phase 1 trial of bel-sar in NMIBC
3/24/2025 - The Fly
Positive Data from Phase 1 Trial of Bel-sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress
3/24/2025 - Globe Newswire
Aura Biosciences (AURA, $7.42) Aroon Indicator entered a Downtrend on March 20, 2025.
3/21/2025 - Tickeron - Stocks
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$94.89M
EBIT (TTM)
-$96.11M
Net Income (TTM)
-$86.92M
Balance Sheet
Total Assets (Q)
$182.50M
Total Debt (Q)
$18.77M
Total Liabilities (Q)
$30.53M
Book Value Per Share (Q)
$3.04
Cash Flow
Cash from Operations (TTM)
-$79.81M
Cash from Investing (TTM)
$68.82M
Cash from Financing (TTM)
$1.60M
Net Change in Cash (TTM)
-$9.39M
Filings
Filing Date
Monday, March 24, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Loading...
Beta
1.58
7-Day Total Return
-11.33%
30-Day Total Return
-22.77%
60-Day Total Return
-26.03%
90-Day Total Return
-36.69%
Year to Date Total Return
-31.94%
1-Year Total Return
-22.56%
2-Year Total Return
-34.86%
3-Year Total Return
-70.78%
5-Year Total Return
--
52-week Low
Apr 07, 2025 - $5.08
52-week High
Oct 18, 2024 - $12.38
Valuation
Market Cap
$277.24M - Micro Cap
Enterprise Value
$144.92M
Price/Sales (TTM)
--
Price/Book (Q)
1.82
Dividends and Shares
Shares Outstanding
49.94M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.aurabiosciences.com
Phone Number
617 500 8864
Address
80 Guest Street
Boston, MA 02135
Country
United States
Year Founded
2009
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision immunotherapies to treat a range of solid tumors. The company’s proprietary platform enables the targeting of a... more
NASDAQ 04/09/2025 2:01PM Eastern Quotes delayed
Weiss Ratings